Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Lattice-tip Versus Irrigated-tip Catheter for Linear Ablation of the Cavotricuspid Isthmus. A Multicenter, Randomized Study. [NA]
A multicenter randomized trial comparing lattice-tip versus irrigated-tip catheters for linear ablation of the cavotricuspid isthmus (CTI) i…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED) [NA]
A clinical trial update describes using left atrial CT imaging to rule out thrombus before cardioversion in patients with atrial fibrillatio…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Anatomical Navigation for Guided Electrophysiology in AFL and AFib [NA]
A clinical trial sponsored by LUMA Vision Ltd is recruiting to evaluate anatomical navigation for guided electrophysiology in atrial fibrill…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures [NA]
Feasibility study update for the VERAFEYE imaging and navigation system used to guide catheter ablation in atrial fibrillation and atrial fl…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study [NA]
Post-market clinical follow-up study of the iCLAS Cryoablation System by Adagio Medical has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation [NA]
A University of Massachusetts study is exploring storytelling as a method to reduce disparities in anticoagulation use among African America…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Atrial Flutter Ablation in the iCMR [NA]
Recruitment is ongoing for a study evaluating atrial flutter ablation using intracardiac MRI (iCMR) technology, sponsored by Imricor Medical…
-
FDA approval · 2026-04-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from ScieGen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form [Phase 2]
Phase 2 trial update describing dose selection and evaluation of the effectiveness and safety of Refralon tablets (1 mg) for long-term preve…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: HeartBeam ECG Registry
This update discusses the HeartBeam ECG Registry, a study of ECG data in atrial fibrillation, atrial flutter, bradycardia, tachycardia and o…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter [NA]
This clinical trial update notes ongoing recruitment for a study assessing intra-abdominal pressure during pulsed-field ablation treatment f…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
This clinical trial update discusses evidence that baseline atrial fibrosis may predict the risk of developing post-operative atrial fibrill…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Impact of Catheter Ablation on ABC Risk Scores
A completed Hannover Medical School clinical study evaluating the impact of catheter ablation on ABC risk scores in atrial fibrillation and …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation [NA]
A clinical trial is evaluating early rhythm control therapy for patients with subclinical atrial fibrillation and is currently recruiting pa…
-
FDA approval · 2026-02-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for diltiazem hydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2026-02-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from Zydus Pharmaceuticals USA Inc., approving a generic product.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter [NA]
This is an update on a clinical trial evaluating pulsed-field ablation for recurrent atypical atrial flutter and atrial flutter; the study i…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Safety and Initial Efficacy Study of a Cardiac Surgical Pulsed Field Ablation System for the Treatment of Atrial Fibrillation [NA]
This clinical trial update describes a cardiac surgical pulsed field ablation system being studied for atrial fibrillation, with the trial s…
-
FDA approval · 2026-02-09FDA Approved: DIGOXIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Digoxin submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Intracardiac Echocardiography-Guided Cavotricuspid Isthmus Ablation With a Circular-Shaped Pulsed Field Ablation Catheter
This clinical trial update describes intracardiac echocardiography-guided cavotricuspid isthmus ablation using a circular-shaped pulsed fiel…
-
FDA approval · 2026-01-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Slate Run Pharmaceuticals, LLC)
FDA approved a supplemental application for a generic diltiazem hydrochloride product from Slate Run Pharmaceuticals, LLC under an ANDA.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments
The clinical trial NCT07239804 evaluates the long-term effectiveness of treatments for stable atrial tachycardia in inpatient and outpatient…
-
FDA approval · 2025-11-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves the original application for diltiazem hydrochloride (Alembic Pharmaceuticals Limited), a generic product, for use in treating …
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate [Phase 4]
Phase 4 clinical trial update evaluating diltiazem for atrial fibrillation or atrial flutter with rapid ventricular rate; results have been …
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR [Phase 3]
Phase 3 trial comparing 2 g and 4 g magnesium sulfate versus placebo for atrial fibrillation with rapid ventricular response is currently re…